Ove Andrén

8.2k total citations · 2 hit papers
95 papers, 5.0k citations indexed

About

Ove Andrén is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ove Andrén has authored 95 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Ove Andrén's work include Prostate Cancer Treatment and Research (41 papers), Prostate Cancer Diagnosis and Treatment (31 papers) and Cancer, Lipids, and Metabolism (16 papers). Ove Andrén is often cited by papers focused on Prostate Cancer Treatment and Research (41 papers), Prostate Cancer Diagnosis and Treatment (31 papers) and Cancer, Lipids, and Metabolism (16 papers). Ove Andrén collaborates with scholars based in Sweden, United States and United Kingdom. Ove Andrén's co-authors include Swen‐Olof Andersson, Jennifer R. Rider, Katja Fall, Jan‐Erik Johansson, Hans‐Olov Adami, Lorelei A. Mucci, Lars Holmberg, Hans Garmo, Anna Bill‐Axelson and Jessica Carlsson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Ove Andrén

94 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

2014 643 citations Anna Bill‐Axelson, Lars Holmberg et al. New England Journal of Medicine profile →
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up

2018 284 citations Anna Bill‐Axelson, Lars Holmberg et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ove Andrén

Since Specialization

Citations

This map shows the geographic impact of Ove Andrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ove Andrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ove Andrén more than expected).

Fields of papers citing papers by Ove Andrén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ove Andrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ove Andrén. The network helps show where Ove Andrén may publish in the future.

Co-authorship network of co-authors of Ove Andrén

This figure shows the co-authorship network connecting the top 25 collaborators of Ove Andrén. A scholar is included among the top collaborators of Ove Andrén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ove Andrén. Ove Andrén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer 2025 ·European Urology ·Lars Holmberg, Hans Garmo, Stefan Andersson, Ove Andrén, Eva Johansson, Kimmo Taari, Michael Häggman, Stig Nordling, Hans‐Olov Adami, Anna Bill‐Axelson	0
2	Cystectomy for bladder cancer in Sweden – short-term outcomes after centralization 2024 ·Scandinavian Journal of Urology ·Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Ove Andrén, (unknown), Truls Gårdmark, Viveka Ströck, (unknown)	1
3	No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study 2019 ·World Journal of Urology ·(unknown), Ruoqing Chen, Fredrik Liedberg, Ove Andrén, Viveka Ströck, Firas Aljabery, Abolfazl Hosseini, Amir Sherif, Per‐Uno Malmström, Anders Ullén, Truls Gårdmark, Katja Fall	18
4	Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up breakdown → 2018 ·New England Journal of Medicine ·Anna Bill‐Axelson, Lars Holmberg, Hans Garmo, Kimmo Taari, Christer Busch, Stig Nordling, Michael Häggman, Swen‐Olof Andersson, Ove Andrén, Gunnar Steineck, Hans‐Olov Adami, Jan‐Erik Johansson	284
5	The MRPS18-2 protein levels correlate with prostate tumor progression and it induces CXCR4-dependent migration of cancer cells 2018 ·Scientific Reports ·(unknown), Lasse D. Jensen, Sabina Davidsson, (unknown), Ove Andrén, В. И. Кашуба, Elena Kashuba	17
6	Cholesterol Metabolism and Prostate Cancer Lethality 2016 ·Cancer Research ·Konrad H. Stopsack, Travis Gerke, Jennifer A. Sinnott, Kathryn L. Penney, Svitlana Tyekucheva, Howard D. Sesso, (unknown), Ove Andrén, James R. Cerhan, Edward L. Giovannucci, Lorelei A. Mucci, Jennifer R. Rider	68
7	Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer 2016 ·Infectious Agents and Cancer ·Sabina Davidsson, Paula Mölling, Jennifer R. Rider, Magnus Unemo, Mats G. Karlsson, Jessica Carlsson, Swen‐Olof Andersson, Fredrik Elgh, Bo Söderquist, Ove Andrén	71
8	The Proteome of Primary Prostate Cancer 2015 ·European Urology ·Diego Iglesias‐Gato, Pernilla Wikström, Stefka Tyanova, (unknown), Elin Thysell, Jessica Carlsson, Christina Hägglöf, Jürgen Cox, Ove Andrén, Pär Stattin, Lars Egevad, Anders Widmark, Anders Bjartell, Colin C. Collins, Anders Bergh, Tamar Geiger, Matthias Mann, Amilcar Flores‐Morales	107
9	Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer breakdown → 2014 ·New England Journal of Medicine ·Anna Bill‐Axelson, Lars Holmberg, Hans Garmo, Jennifer R. Rider, Kimmo Taari, Christer Busch, Stig Nordling, Michael Häggman, Swen‐Olof Andersson, Anders Spångberg, Ove Andrén, Juni Palmgren, Gunnar Steineck, Hans‐Olov Adami, Jan‐Erik Johansson	643
10	Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study 2013 ·Cancer Causes & Control ·Kathryn M. Wilson, Katarina Bälter, Elisabeth Möller, Hans‐Olov Adami, Ove Andrén, Swen‐Olof Andersson, Henrik Grönberg, Lorelei A. Mucci	11
11	Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case–control study 2013 ·Journal of Nutritional Science ·Elisabeth Möller, Carlotta Galeone, Therése Andersson, Rino Bellocco, Hans‐Olov Adami, Ove Andrén, Henrik Grönberg, Carlo La Vecchia, Lorelei A. Mucci, Katarina Bälter	35
12	CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer 2012 ·Modern Pathology ·Sabina Davidsson, (unknown), Swen‐Olof Andersson, Katja Fall, Allison Meisner, Michelangelo Fiorentino, Ove Andrén, Jennifer R. Rider	83
13	Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue 2012 ·Cancer Causes & Control ·Mara M. Epstein, Ove Andrén, Julie L. Kasperzyk, Irene M. Shui, Kathryn L. Penney, Katja Fall, Jennifer R. Rider, Meir J. Stampfer, Swen‐Olof Andersson, Edward L. Giovannucci, Lorelei A. Mucci	5
14	Multilocus sequence typing and repetitive-sequence-based PCR (DiversiLab) for molecular epidemiological characterization of Propionibacterium acnes isolates of heterogeneous origin 2012 ·Anaerobe ·Sabina Davidsson, Bo Söderquist, Fredrik Elgh, Jan Olsson, Ove Andrén, Magnus Unemo, Paula Mölling	16
15	Molecular sampling of prostate cancer: a dilemma for predicting disease progression 2010 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Philip W. Kantoff, Meir J. Stampfer, (unknown), Eberhard Varenhorst, (unknown), Mark Gerstein, Todd R. Golub, Mark A. Rubin, Ove Andrén	178
16	One-carbon metabolism-related nutrients and prostate cancer survival 2009 ·American Journal of Clinical Nutrition ·Julie L. Kasperzyk, Katja Fall, Lorelei A. Mucci, Niclas Håkansson, Alicja Wolk, Jan‐Erik Johansson, Swen‐Olof Andersson, Ove Andrén	23
17	Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study 2009 ·PLoS Medicine ·Katja Fall, Fang Fang, Lorelei A. Mucci, Weimin Ye, Ove Andrén, Jan‐Erik Johansson, Swen‐Olof Andersson, Pär Sparén, Georg Klein, Meir J. Stampfer, Hans‐Olov Adami, Unnur Valdimarsdóttir	98
18	Natural history and prognostic factors in localized prostate cancer 2008 ·Europe PMC (PubMed Central) ·Ove Andrén	29
19	Testing a multigene model to predict lethal prostate cancer 2008 ·Modern Pathology ·(unknown), (unknown), (unknown), Francesca Demichelis, Katja Fall, (unknown), (unknown), S-O Andersson, Ove Andrén, Lars Holmberg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer specific death 2005 ·Laboratory Investigation ·Mark A. Rubin, (unknown), Ove Andrén, (unknown), (unknown), Rongfang Shen, Deepraj Ghosh, (unknown), AM Chinnaiyan, H-O Adami, Philip W. Kantoff, J-E Johansson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact